Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Launched by M.D. ANDERSON CANCER CENTER · May 29, 2025
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating and testing educational materials to help people understand how to prevent liver cancer. The goal is to develop easy-to-use information that can guide patients on lifestyle choices and actions that may lower their risk of developing this type of cancer.
To participate in this study, you should be at least 18 years old and able to read and speak either English or Spanish. Participants need to be patients at the HOPE Clinic and should be comfortable using a smartphone or computer to navigate websites. If someone has already been diagnosed with liver cancer or has difficulties participating in research due to conditions like vision or hearing impairments, they won't be eligible for this trial. If you join the study, you can expect to review and provide feedback on the educational tools being developed, helping to ensure they are clear and useful for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years old
- • Participants at the HOPE Clinic
- • Able to speak and read either English or Spanish
- • For usability testing: Able to use and navigate websites on own smart phone or study computer
- Exclusion Criteria:
- • Has been diagnosed with liver cancer
- • Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Jessica Hwang, MD, MPH
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported